Putnam BioRevolution ETF
SYNB
SYNB was delisted on the 13th of November, 2025.
4 hedge funds and large institutions have $4.26M invested in Putnam BioRevolution ETF in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
33% more funds holding
Funds holding: 3 → 4 (+1)
8% more capital invested
Capital invested by funds: $3.93M → $4.26M (+$333K)
2.18% more ownership
Funds ownership: 70% → 72.18% (+2.2%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$125K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
+$64 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$32 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Franklin Resources
San Mateo,
California
| $4.1M | – | – | – |
|
|
2
Royal Bank of Canada
Toronto,
Ontario, Canada
| $162K | +$125K | +3,919 | +396% |
|
|
3
UBS Group
Zurich,
Switzerland
| $364 | -$32 | -1 | -8% |
|
|
4
Osaic Holdings
Scottsdale,
Arizona
| $66 | +$64 | +2 | New |
|
SYNB Hedge Fund Activity: Q3 2024 in Review
4 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Putnam BioRevolution ETF (SYNB) for Q3 2024, worth a combined $4.26M — up 8.5% from $3.93M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new SYNB positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Royal Bank of Canada, adding an estimated $125K. The largest seller was UBS Group, cutting an estimated $32.
- 4 institutional investors held Putnam BioRevolution ETF (SYNB) as of Q3 2024, up from 3 in Q2 2024.
- Funds reported $4.26M of Putnam BioRevolution ETF stock for Q3 2024, up 8.5% quarter-over-quarter.
- 1 fund opened new Putnam BioRevolution ETF positions in Q3 2024 and 0 closed out, a net change of +1 holder.
- The largest Putnam BioRevolution ETF buyer in Q3 2024 was Royal Bank of Canada, an estimated $125K added.
- The largest Putnam BioRevolution ETF seller in Q3 2024 was UBS Group, an estimated $32 sold.
Based on aggregated 13F filings for Q3 2024.